Overall, prevalence and incidence of depression and anxiety increased in younger populations, notably from 1.83% in 2017 to 2.85% in 2021 for ages 5 to 17. The prevalence of depression and anxiety ...
Dec. 17, 2024 — Almost three quarters of adolescents in Australia experience clinically significant depression or anxiety symptoms, with most being chronic, according to a new study. And ...
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), which can ...
Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with ...
Maternal mortality rates have soared in the U.S. to nearly three times those of other high-income countries. Over 20 percent of deaths among new mothers are from suicide and overdose. Researchers and ...
Rates of anxiety and depression increased to 65 percent and 61 percent, respectively, of the respondents in that age group, according to the report. Use of prescription medication, counseling services ...